Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Apr 20, 2024 7:05am
59 Views
Post# 35999354

RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

mdjbrown wrote: Dont forget okgonow, the settlement with Tilray included $1 million in product which will help.

Non-cash elements also included in the Settlement Agreement are ongoing product considerations:

  • § $1,000,000 in Tilray products (including but not restricted to high-quality flower and extractable biomass).
  • § $500,000 four-year supply agreement to provide Tilray with MediPharm products and services.

 

md... how far will a million $ in flower take you they said they have orders for drobinol of 1.5 mill in first Q alone that's just one of their products at let's say a 50% profit margin ( just to make the math easy also I know there are other manufacturing costs involved so this is the 2 minute math)you would need $500k to $750k of raw product to produce the order.

your chewing through a lot of stock again just one of their products 

and if we assume that sales of other API's and products going forward will pick up dramatically we will need allot more of flower to refine 

<< Previous
Bullboard Posts
Next >>